{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:04:50Z","timestamp":1782248690523,"version":"3.54.5"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":915,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"British Heart Foundation Centre of Research Excellence","award":["PG\/2019\/35089"],"award-info":[{"award-number":["PG\/2019\/35089"]}]},{"name":"British Heart Foundation Centre of Research Excellence","award":["RE\/18\/6134217"],"award-info":[{"award-number":["RE\/18\/6134217"]}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Transferrin saturation (TSAT), a marker of iron deficiency, reflects both serum concentrations of iron (SIC) and transferrin (STC). TSAT is susceptible to changes in each of these biomarkers. Little is known about determinants of STC and its influence on TSAT and mortality in patients with heart failure. Accordingly, we studied the relationship of STC to clinical characteristics, to markers of iron deficiency and inflammation and to mortality in chronic heart failure (CHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Prospective cohort of patients with CHF attending a clinic serving a large local population. A total of 4422 patients were included (median age 75 (68\u201382) years; 40% women; 32% with left ventricular ejection fraction \u226440%). STC \u2264 2.3 g\/L (lowest quartile) was associated with older age, lower SIC and haemoglobin and higher high-sensitivity C-reactive protein, ferritin and N-terminal pro-brain natriuretic peptide compared with those with STC &amp;gt; 2.3 g\/L. In the lowest STC quartile, 624 (52%) patients had SIC \u226413 \u03bcmol\/L, of whom 38% had TSAT \u226520%. For patients in the highest STC quartile, TSAT was &amp;lt;20% when SIC was &amp;gt;13 \u03bcmol\/L in 185 (17%) patients. STC correlated inversely with ferritin (r = \u22120.52) and high-sensitivity C-reactive protein (r = \u22120.17) and directly with albumin (r = 0.29); all P &amp;lt; 0.001. In models adjusted for age, N-terminal pro-brain natriuretic peptide and haemoglobin, both higher SIC (hazard ratio 0.87 [95% CI: 0.81\u20130.95]) and STC (hazard ratio 0.82 [95% CI: 0.73\u20130.91]) were associated with lower mortality. SIC was more strongly associated with both anaemia and mortality than either STC or TSAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Many patients with CHF and a low STC have low SIC even when TSAT is &amp;gt;20% and serum ferritin &amp;gt;100 \u03bcg\/L; such patients have a high prevalence of anaemia and a poor prognosis and might have iron deficiency but are currently excluded from clinical trials of iron repletion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14438","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:38:40Z","timestamp":1688431120000},"page":"2826-2836","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Influence of Serum Transferrin Concentration on Diagnostic Criteria for Iron Deficiency in Chronic Heart Failure"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-9958","authenticated-orcid":false,"given":"Fraser J.","family":"Graham","sequence":"first","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Masini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Cuthbert","sequence":"additional","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust , Hull ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[{"name":"Hull University Teaching Hospitals NHS Trust , Hull ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G. F.","family":"Cleland","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"2026012113215828400_ehf214438-bib-0001","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0002","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ejhf.2036","article-title":"High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality","volume":"23","author":"Sierpinski","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012113215828400_ehf214438-bib-0003","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Beverborg","year":"2018","journal-title":"Circ Hear Fail"},{"key":"2026012113215828400_ehf214438-bib-0004","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"2026012113215828400_ehf214438-bib-0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"2026012113215828400_ehf214438-bib-0006","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113215828400_ehf214438-bib-0007","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026012113215828400_ehf214438-bib-0008","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026012113215828400_ehf214438-bib-0009","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012113215828400_ehf214438-bib-0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"135","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"2026012113215828400_ehf214438-bib-0011","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026012113215828400_ehf214438-bib-0012","first-page":"71","article-title":"Transferrin saturation: a body iron biomarker","author":"Elsayed","year":"2016","journal-title":"Adv Clin Chem"},{"key":"2026012113215828400_ehf214438-bib-0013","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026012113215828400_ehf214438-bib-0014","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use","volume":"40","author":"van der Wal","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"2026012113215828400_ehf214438-bib-0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2017.04.110","article-title":"Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure","volume":"243","author":"Moliner","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0016","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0017","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/eurjpc\/zwaa112","article-title":"Prognostic role of transferrin saturation in heart failure patients","volume":"28","author":"Campodonico","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0018","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0019","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ejhf.2251","article-title":"Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure","volume":"24","author":"Graham","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026012113215828400_ehf214438-bib-0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","journal-title":"J Am Coll Cardiol"},{"key":"2026012113215828400_ehf214438-bib-0021","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113215828400_ehf214438-bib-0022","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System","author":"WHO","year":"2011"},{"key":"2026012113215828400_ehf214438-bib-0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026012113215828400_ehf214438-bib-0024","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ejhf.785","article-title":"Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure","volume":"19","author":"Voors","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012113215828400_ehf214438-bib-0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026012113215828400_ehf214438-bib-0026","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"2026012113215828400_ehf214438-bib-0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/asheducation-2015.1.8","article-title":"Iron deficiency: new insights into diagnosis and treatment","volume":"2015","author":"Camaschella","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2026012113215828400_ehf214438-bib-0028","volume-title":"Biochemistry, Transferrin. StatPearls","author":"Ogun","year":"2018"},{"key":"2026012113215828400_ehf214438-bib-0029","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.120.047019","article-title":"Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure: the ARIC study community surveillance","volume":"142","author":"Pandey","year":"2020","journal-title":"Circulation"},{"key":"2026012113215828400_ehf214438-bib-0030","doi-asserted-by":"crossref","first-page":"73.e1","DOI":"10.1016\/j.ajog.2009.07.049","article-title":"Validation of serum biomarkers for detection of early- and late-stage endometrial cancer","volume":"202","author":"Farias-Eisner","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"2026012113215828400_ehf214438-bib-0031","doi-asserted-by":"crossref","first-page":"639.e1","DOI":"10.1016\/j.ajog.2008.12.042","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2026012113215828400_ehf214438-bib-0032","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fonc.2020.00476","article-title":"Altered iron metabolism and impact in cancer biology, metastasis, and immunology","volume":"10","author":"Brown","year":"2020","journal-title":"Front Onc"},{"key":"2026012113215828400_ehf214438-bib-0033","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/ph11030082","article-title":"Intravenous irons: from basic science to clinical practice","volume":"11","author":"Bhandari","year":"2018","journal-title":"Pharmaceuticals"},{"key":"2026012113215828400_ehf214438-bib-0034","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1592\/phco.24.6.574.34750","article-title":"Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects","volume":"24(5 I):574\u201383","author":"Seligman","year":"2004","journal-title":"Pharmacotherapy"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/5\/2826\/66227995\/eschf_10_5_2826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/5\/2826\/66227995\/eschf_10_5_2826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:26:47Z","timestamp":1769020007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/5\/2826\/8284445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,7,3]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14438","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"2023-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}